The seizure-related syndromes known collectively as the epilepsies represent one of the most common neurological disorders in dogs, and are thus a significant concern in canine health. These disorders have a wide range of severities, precipitating causes, comorbidities, and treatment outcomes. As such, epilepsy is of major concern to the AKC Canine Health Foundation and has prompted the establishment of a separate Epilepsy Research Program with unique requirements.
Recently funded grant titles:
- Efficacy of Cannabidiol (CBD) for the Treatment of Canine Epilepsy
- Identification of Genetic Risk Factors for Canine Epilepsy
- Investigating a Ketogenic Medium-Chain Triglyceride (MCT) Supplement for the Treatment of Drug-Resistant Canine Idiopathic Epilepsy and Its Behavioral Comorbidities
- Identification of a Novel Juvenile Myoclonic Epilepsy Gene and Its Underlying Disease Mechanism
- Canine Epilepsy: Genetic Variants, Biomarkers, and New Therapies
- Identifying the Genetic Cause of Epilepsy
- Identification of Epilepsy-Causing Mutations from the Associated Loci by Next-Generation Resequencing
- Studying the Role of the Gastrointestinal Tract in Canine Epilepsy
- Neurostimulation: A Groundbreaking New Treatment for Canine Epilepsy
- A Pilot Study: Establishing the Role of Melatonin in the Occurrence of Seizures in Dogs
The AKC Canine Health Foundation funds research in 18 different Research Program Areas. These program areas enable the Foundation to create depth in our research portfolio and help us to be responsive to the health concerns of our constituents.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.